Literature DB >> 10048767

Dietary omega-3 polyunsaturated fatty acids reduce IFN-gamma receptor expression in mice.

C Feng1, D H Keisler, K L Fritsche.   

Abstract

Enrichment of immune cells in vivo or in vitro with omega-3 polyunsaturated fatty acid (n-3 PUFA) has been reported to diminish their response to interferon-y (IFN-gamma). We hypothesized that the n-3 PUFA-induced hyporesponsiveness to IFN-gamma is mediated, in part, by a reduction in the number of IFN-gamma receptors (IFNGR) expressed on the surface of these cells. To test this hypothesis, we fed mice experimental diets containing low or high amounts of n-3 PUFA. Thioglycollate-elicited peritoneal macrophages (PEC) were collected and tested for binding and internalization of [125I]-labeled recombinant murine IFN-gamma. High n-3 PUFA intake was associated with a significant (n = 2, p < 0.01) reduction in [125I]-IFN-gamma binding without affecting binding affinity (Kd). When studies were performed at 37 degrees C, high n-3 PUFA intake reduced internalization of [125I]-rmIFN-gamma by 20%-30% (n = 2,p < 0.001). Results from flow cytometric analysis of IFNGR-1 expression on the surface of murine splenocytes were in agreement with the binding studies. Further, total cellular IFNGR-1 from PEC and splenocytes was examined via immunoprecipitation and Western blotting. High n-3 PUFA diet was associated with a 50% decline (n = 3-6, p < 0.05) in total IFNGR-1 in both immune cell populations studied. These data suggest that reduced IFNGR expression may be responsible for immune cell hyporesponsiveness to IFN-gamma, which may, in part, explain some of the immunomodulatory and anti-inflammatory effects associated with the consumption of diets high in n-3 PUFA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048767     DOI: 10.1089/107999099314405

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  The importance of omega-3 fatty acids in the attenuation of immune-mediated diseases.

Authors:  P Kehn; G Fernandes
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 2.  Polyunsaturated fatty acids, inflammation, and immunity.

Authors:  P C Calder
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

3.  Adhesion of MC3T3-E1 cells bound to dentin phosphoprotein specifically bound to collagen type I.

Authors:  Kevin M Zurick; Chunlin Qin; Matthew T Bernards
Journal:  J Biomed Mater Res A       Date:  2012-05-21       Impact factor: 4.396

4.  Mineralization induction effects of osteopontin, bone sialoprotein, and dentin phosphoprotein on a biomimetic collagen substrate.

Authors:  Kevin M Zurick; Chunlin Qin; Matthew T Bernards
Journal:  J Biomed Mater Res A       Date:  2012-11-14       Impact factor: 4.396

5.  Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids.

Authors:  Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2002

6.  Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages.

Authors:  Wei Lei; Jimmy D Browning; Peggy A Eichen; Korey J Brownstein; William R Folk; Grace Y Sun; Dennis B Lubahn; George E Rottinghaus; Kevin L Fritsche
Journal:  Int Immunopharmacol       Date:  2015-11-12       Impact factor: 4.932

Review 7.  Relationship between dietary patterns and COPD: a systematic review and meta-analysis.

Authors:  Michael K Parvizian; Manreet Dhaliwal; Jeremy Li; Imran Satia; Om P Kurmi
Journal:  ERJ Open Res       Date:  2020-05-11

8.  An Investigation into the Immunomodulatory Activities of Sutherlandia frutescens in Healthy Mice.

Authors:  Wei Lei; Jimmy D Browning; Peggy A Eichen; William R Folk; Grace Y Sun; Dennis B Lubahn; Kevin L Fritsche
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

Review 9.  Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era.

Authors:  Leila Abdelhamid; Xin M Luo
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.